A recent survey reveals that Western pharma companies are still shying away from outsourcing preclinical work to Asia. Meanwhile, Covance and Charles River clearly dominate this niche industry sector.

-----------------------------------------------------------------------------------------

This is not an article published by Pharma China, and please visit the following website link for the full text of the article.  The availability of the article is under the control of its publisher.  

http://www.drugresearcher.com/news/ng.asp?n=79411-lehman-brothers-asia-preclinical-outsourcing

Note: By clicking on the above link, you will leave Pharma China Online. If you wish to return to this website, please click on "Back" button or log onto Pharma China Online again.